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A case of gastric polyposis in antral area of stomach
following prolonged proton-pump therapy
Polyposis des Magens nach Therapie mit Protonenpumpenhemmer –
ein Fallbericht
Abstract
We describe the clinical scenario of a young male with history of non
ulcer dyspepsia who had endoscopic evidence of gastric polyposis in
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antral area. The polyps disappeared four months after proton pump
inhibitors were stopped. Proton pump inhibitors have been linked to
gastric fundal polyposis and not antral gland polyposis. This is the first 1 Department of
Gastroenterology,KingFahad reportoriginatingfromanAsiancountrydescribingantralglandpolyposis
Medical City, Riyadh, Saudi
Arabia
(AGPs) in a patient on long-term PPI therapy with no evidence of
Helicobacter pylori. A case report with brief review is presented.
Keywords: proton pump inhibitors, hyperplastic gastric polyps, antral
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Zusammenfassung
Es wird der Fall eines jungen Mannes berichtet, bei dem endoskopisch
eine Polyposis des Magens im antralen Bereich nachgewiesen wurde.
Die Polyposis verschwand vier Monate nach Absetzen der Therapie mit
einem Protonenpumpenhemmer. Die Wirkung von Protonenpumpen-
hemmern auf die Entstehung von Polypen im Fundus ist beschrieben,
nicht jedoch im antralen Bereich.
DiesistderersteBerichtauseinemasiatischenLandübereineMagen-
Polypose im antralen Bereich, aufgetreten nach einer Langzeittherapie
mit Protonenpumpenhemmern. Eine Infektion mit Helicobacter pylori
war nicht nachweisbar, ebenso fehlten Ulzerationen.
Schlüsselwörter:Protonenpumpeninhibitoren,hyperplastischePolyposis,
antraler Bereich des Magens
Introduction
Fundicglandpolypsarenowcommonlyrecognisedduring
endoscopyandtheiroccurrenceisattributedtoprolonged
proton pump inhibitor (PPI) therapy [1]. These polyps are
benign,oftenmultipleandareusuallydetectedingastric
body and fundus. However, the polyps in antral area are
oftenattributedtoinfectionwithH.pylori[2].Weobserved
thatourpatienthadnoevidenceofH.pyloriinfectionand
had polyps in antral area. These polyps disappeared four
months after stopping PPI therapy establishing a cause
and effect relationship. This case report reflects the dif-
fuse effect of PPI therapy in causing antral polyposis.
Case description
A 30 year old male presented to our clinic with history of
onandoffepigastricpainof4yearsdurationwithoutany
alarmingsymptoms.Thepatienthadnohistoryofoffend-
ing drug intake. He had been taking proton pump inhibi-
tors Tab. Esomeprazole 20 mg twice daily continuously
for 4 years with partial relief. He has been a non smoker
anddeniedanydrugabuseoralcoholintake.Hissystemic
examination was unremarkable. He was evaluated on
outpatient basis. He had haemoglobin of 14 g/dl with
normal leucocytic count and normal platelet count. He
had normal liver and kidney function tests. Serum amyl-
ase was within normal limits. Abdominal ultrasound
showed a normal size of the liver with its normal echo
texture. There were no gall stones, the common bile duct
was normal and other abdominal viscera were also nor-
mal. The patient underwent upper gastrointestinal (GI)
endoscopy which revealed a normal esophagus and a
small hiatal hernia. There were multiple polyps in the
antral area, each around 1 cm (Figure 1). A biopsy was
takenfromthesepolypsandaCampylobacter-likeorgan-
ism (CLO) test was also done. The patient's biopsy
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Case Report OPEN ACCESS(Figure 2) revealed evidence of chronic gastritis with no
H. pylori activity. The polyp was adenomatous with no
features of malignancy. His serology for H. pylori was
negative. The patient had a normal colonscopic examin-
ation and familial polyposis was ruled out.
Figure1:Endoscopyshowingmultiplepolypsintheantralarea
of the stomach
Figure 2: Histology of the polyp
Proton pump inhibitors were stopped and upper GI endo-
scopy wasrepeated after 4 months (Figure3). There was
almost disappearance of the antral polypoidal lesions.
Repeated histology of the antral area showed complete
regressionofthepolypwithmildgastritisandnoH.pylori
(Figure 4). No H. pylori was grown after culture. The pa-
tientwasgivenreassuranceandsymptomatictreatment.
He is doing well and is following our clinic for 6 months
now. The polypoid lesions were attributed to prolonged
PPI usage and a CYP gene analysis (Table 1) was done.
The index case was found to have one copy of the gene
encoding enzyme with normal activity and another copy
coding for inactive enzyme.
Figure 3: Disappearance of the polyps after stopping PPI
therapy
Figure 4: Histology of the antrum, no polyps and no H. pylori
seen
Table 1: CYP2C19 sequence genotype of the index case
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The relative prevalence of fundic gland polyps on routine
endoscopy has increased in recent years. An American
study [3] of upper gastroscopic examinations over one
year period in 120,000 patients reported increased pre-
valence of gastric polyps higher than earlier reports. This
was most likely because of the widespread use of proton
pump inhibitors. In the same study, authors observed
that H. pylori- and atrophy-associated polyps, including
adenomas, were less common than in earlier series. An-
tral polyposis is often attributed to H. pylori infection,
however the index case had no serological or histological
evidence of H. pylori and responded to stoppage of PPI
therapy. Studies [2] have shown that there is regression
of gastric polyposis when H. pylori is eradicated. This im-
pliesthatpatientswithH.pyloriinfectionmustbetreated
before embarking on more invasive treatments in gastric
polyposis as often these are multiple. Our patient had
polyposis in antral area clearly due to prolonged PPI
therapy and the patient's polyps disappeared after PPI
were stopped. Proton-pump inhibitors have remained
centraltothemanagementofacid-suppressiondisorders
for more than two decades now and are unchallenged
withregardtotheirefficacyandpopularityamongdoctors
and patients [4]. Side effects of PPI therapy include re-
versible hypergastrinemia, enterochromaffin-like hyper-
plasia, and possibly acceleration of atrophic gastritis in
the gastric corpus in patients with H. pylori infection.
Studieshaveshownthatlong-termprotonpumpinhibitor
use is associated with an up to fourfold increase in the
risk of fundic gland polyps. The risk of dysplasia is negli-
gible in gastric polyposis due to PPI use and there is no
association of gastric polyposis with neoplasia [5]. Aetio-
logically, these polyps seem to arise because of parietal
cell hyperplasia and parietal cell protrusions resulting
from acid suppression [6]. The issue of duration of ther-
apy leading to gastric polyposis was addressed by Allay
etal.[7].Theauthorsobservedthattheonlyindependent
predictor of gastric polyp development was a duration of
PPI therapy greater than 48 months. Increased dosage
of therapy in contrast had no significant impact on the
development of gastric polyposis [7]. It was of interest to
determinethegenotypeofCYP2C19,theprincipalenzyme
in PPI metabolism. The rare carriers of the homozygous
deficiencyshowanabouttenfoldhigherexposureofPPIs
following normal doses than those patients who are ho-
mozygous active. Our patient's CYP gene sequencing re-
vealed that he had one copy of the genes encoding nor-
malenzymeactivityandtheothercopyencodinganinact-
ive enzyme. He was thus an intermediate metabolizer of
the drug (Tab. Esomeprazole). This may have led to in-
creased levels for prolonged periods and subsequent
polyposis in antral area. All our efforts to correlate any
associationofthesepolypsintheindexcasewithH.pylori
werenoncontributory,evenH.pyloriculturewasnegative.
Endoscopists need to be familiar with these findings. All
efforts should be done to rule out neoplastic lesion in a
polypoid gastric lesion and a careful follow up seems
mandatory. We documented regression of these polyps
following stoppage of PPI therapy like in other studies
[8]. Long term of PPI usage is difficult to define. Studies
have shown that most of the patients do not require
prolonged PPI therapy and thus there is always need to
rationalisetheirtreatment.Ondemandtherapyhasbeen
shown to be cost effective and should be considered in
most patients [9].
Conclusion
Antral gastric polyps may be encountered during endo-
scopyinpatientstakingPPItherapyforprolongedperiods.
Efforts to eradicate H. pylori and trial of stopping PPI
therapy may be warranted before subjecting these pa-
tients to more invasive procedures. However, follow up
endoscopy to document the regression cannot be under-
estimated in these gastric lesions.
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